These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 17286619

  • 1. The impact of treatment of portopulmonary hypertension on survival following liver transplantation.
    Ashfaq M, Chinnakotla S, Rogers L, Ausloos K, Saadeh S, Klintmalm GB, Ramsay M, Davis GL.
    Am J Transplant; 2007 May; 7(5):1258-64. PubMed ID: 17286619
    [Abstract] [Full Text] [Related]

  • 2. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
    Sağ S, Yeşilbursa D, Güllülü S.
    Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK, Bass NM, De Marco T, Merriman RB.
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis.
    Molnar C, Alber H, Colleselli D, Vogel W, Kähler CM.
    Wien Klin Wochenschr; 2004 Sep 30; 116(17-18):627-30. PubMed ID: 15515882
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of portopulmonary hypertension: new perspectives.
    Mancuso L, Scordato F, Pieri M, Valerio E, Mancuso A.
    World J Gastroenterol; 2013 Dec 07; 19(45):8252-7. PubMed ID: 24363516
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension.
    Uchiyama H, Soejima Y, Taketomi A, Yoshizumi T, Harada N, Ijichi H, Yonemura Y, Maehara Y.
    Liver Transpl; 2006 Mar 07; 12(3):481-4. PubMed ID: 16498645
    [Abstract] [Full Text] [Related]

  • 11. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ, Shin MS, Oh KY, Kim MG, Shin KC, Park YM, Kim BR, Chung WJ, Ahn TH, Choi IS, Shin EK.
    Eur J Gastroenterol Hepatol; 2010 Dec 07; 22(12):1503-5. PubMed ID: 21389799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
    Halank M, Kolditz M, Miehlke S, Schiemanck S, Schmeisser A, Hoeffken G.
    Wien Med Wochenschr; 2005 Aug 07; 155(15-16):376-80. PubMed ID: 16160926
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination therapy for severe portopulmonary hypertension in a child allows for liver transplantation.
    Serrano RM, Subbarao GC, Mangus RS, Montgomery G, Johansen M.
    Pediatr Transplant; 2019 Aug 07; 23(5):e13461. PubMed ID: 31062925
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?
    Kuntzen C, Gülberg V, Gerbes AL.
    Gastroenterology; 2005 Jan 07; 128(1):164-8. PubMed ID: 15633133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.